Piper Sandler Reiterates Neutral on Sight Sciences, Raises Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has reiterated a Neutral rating on Sight Sciences (NASDAQ:SGHT) and raised the price target from $5 to $6.
May 03, 2024 | 1:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained a Neutral rating on Sight Sciences but increased the price target from $5 to $6.
The increase in price target by Piper Sandler suggests a positive outlook on the stock's value, potentially leading to short-term price appreciation. However, the Neutral rating indicates that the analyst sees the stock as fairly valued at its current price, balancing the potential impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90